Montpellier, France

Antonio Maraver

This inventor holds 1 USPTO granted patent. Top assignees: Institut Regional Du Cancer De Montpellier, National Institute of Health and Medical Research, Universitè De Montpellier. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Antonio Maraver. Retrieved from https://idiyas.com/inventor/antonio-maraver

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Antonio Maraver: Innovator in Cancer Treatment

Introduction

Antonio Maraver is a notable inventor based in Montpellier, France. He has made significant contributions to the field of cancer treatment, particularly focusing on lung cancer. His innovative approach combines the use of tyrosine-kinase inhibitors with Notch pathway inhibitors to enhance treatment efficacy.

Latest Patents

Antonio Maraver holds a patent for a combination treatment for cancer. This invention specifically addresses the treatment of lung cancer by analyzing the role of the Notch pathway in EGFR-driven lung adenocarcinoma. The findings indicate that combining EGFR tyrosine kinase inhibitors with Notch inhibition can re-sensitize lung adenocarcinoma cells to treatment. This innovative approach has the potential to improve outcomes for patients with specific mutations.

Career Highlights

Throughout his career, Antonio has worked with prestigious institutions such as Inserm (Institut National de la Santé et de la Recherche Médicale) and Université de Montpellier. His research has focused on understanding the complexities of cancer biology and developing effective treatment strategies.

Collaborations

Antonio has collaborated with Emilie Bousquet, contributing to the advancement of cancer research and treatment methodologies.

Conclusion

Antonio Maraver's work in cancer treatment exemplifies the impact of innovative research on improving patient outcomes. His patented combination therapy represents a significant advancement in the fight against lung cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…